{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:28:40Z","timestamp":1790674120813,"version":"4.1.0"},"reference-count":55,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Loss-of-function events in tumor suppressor genes (TSGs) contribute to the development and progression of cutaneous malignant melanoma (CMM). Epigenetic alterations are the major mechanisms of TSG inactivation, in particular, silencing by promoter CpG-island hypermethylation. TSGs are valuable tools in diagnosis and prognosis and, possibly, in future targeted therapy. The aim of this narrative review is to outline bona fide TSGs affected by promoter CpG-island hypermethylation and their functional role in the progression of CMM. We conducted a systematic literature review to identify studies providing evidence of bona fide TSGs by cell line or animal experiments. We performed a broad first search and a gene-specific second search, supplemented by reference checking. We included studies describing bona fide TSGs in CMM with promoter CpG-island hypermethylation in which inactivating mechanisms were reported. We extracted data about protein role, pathway, experiments conducted to meet the bona fide criteria and hallmarks of cancer acquired by TSG inactivation. A total of 24 studies were included, describing 24 bona fide TSGs silenced by promoter CpG-island hypermethylation in CMM. Their effect on cell proliferation, apoptosis, growth, senescence, angiogenesis, migration, invasion or metastasis is also described. These data give further insight into the role of TSGs in the progression of CMM.<\/jats:p>","DOI":"10.3390\/ijms221910674","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T10:55:40Z","timestamp":1633085740000},"page":"10674","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Bona Fide Tumor Suppressor Genes Hypermethylated in Melanoma: A Narrative Review"],"prefix":"10.3390","volume":"22","author":[{"given":"Canan","family":"G\u00fcven\u00e7","sequence":"first","affiliation":[{"name":"Department of Dermatology, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fien","family":"Neckebroeck","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asier","family":"Antoranz","sequence":"additional","affiliation":[{"name":"Department of Imaging and Pathology, Translational Cell and Tissue Research, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjan","family":"Garmyn","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost","family":"van den Oord","sequence":"additional","affiliation":[{"name":"Department of Imaging and Pathology, Translational Cell and Tissue Research, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8874-2003","authenticated-orcid":false,"given":"Francesca Maria","family":"Bosisio","sequence":"additional","affiliation":[{"name":"Department of Imaging and Pathology, Translational Cell and Tissue Research, University Hospitals Leuven, 3000 Leuven, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"7356","DOI":"10.1002\/jcp.27495","article-title":"Promoter methylation as biomarkers for diagnosis of melanoma: A systematic review and meta-analysis","volume":"234","author":"Guo","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/jso.25604","article-title":"Melanoma","volume":"120","author":"Scoggins","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1600-0749.2007.00378.x","article-title":"Melanoma invasion-Current knowledge and future directions","volume":"20","author":"Gaggioli","year":"2007","journal-title":"Pigment Cell Res."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.7150\/jca.1.136","article-title":"Functional Mechanisms for Human Tumor Suppressors","volume":"1","author":"Sun","year":"2010","journal-title":"J. Cancer"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2230.2000.00620.x","article-title":"Tumour suppressor genes","volume":"25","author":"Swale","year":"2000","journal-title":"Clin. Exp. Dermatol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"30165","DOI":"10.18632\/oncotarget.5030","article-title":"RASSF8 regulates progression of cutaneous melanoma through nuclear factor-kappab","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/neuonc\/nou107","article-title":"DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterations","volume":"16","author":"Marzese","year":"2014","journal-title":"Neuro-Oncology"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1248\/bpb.b15-01026","article-title":"FAD104, a Regulator of Adipogenesis and Osteogenesis, Interacts with the C-Terminal Region of STAT3 and Represses Malignant Transformation of Melanoma Cells","volume":"39","author":"Katoh","year":"2016","journal-title":"Biol. Pharm. Bull."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4422","DOI":"10.1128\/MCB.00706-13","article-title":"The FBXO4 Tumor Suppressor Functions as a Barrier to BrafV600E-Dependent Metastatic Melanoma","volume":"33","author":"Lee","year":"2013","journal-title":"Mol. Cell. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.jid.2016.01.024","article-title":"Promoter Methylation of PTEN Is a Significant Prognostic Factor in Melanoma Survival","volume":"136","author":"Roh","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_11","first-page":"1475","article-title":"Genetic alterations of PTEN in human melanoma","volume":"69","author":"Li","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1111\/j.1755-148X.2010.00773.x","article-title":"p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation","volume":"23","author":"Terzian","year":"2010","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ccell.2018.05.014","article-title":"Bi-allelic Loss of CDKN2A Initiates Melanoma Invasion via BRN2 Activation","volume":"34","author":"Zeng","year":"2018","journal-title":"Cancer Cell"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1023\/A:1009571417429","article-title":"Mannose 6-phosphate\/insulin-like growth factor 2 receptor, a bona fide tumor suppressor gene or just a promising candidate?","volume":"5","author":"Dacosta","year":"2000","journal-title":"J. Mammary Gland Biol. Neoplasia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1158\/0008-5472.CAN-15-3371","article-title":"Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations","volume":"76","author":"Kadariya","year":"2016","journal-title":"Cancer Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.1038\/onc.2014.367","article-title":"Mcph1\/Brit1 deficiency promotes genomic instability and tumor formation in a mouse model","volume":"34","author":"Liang","year":"2015","journal-title":"Oncogene"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/sj.onc.1206064","article-title":"DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity","volume":"22","author":"Yuan","year":"2003","journal-title":"Oncogene"},{"key":"ref_18","first-page":"G1124","article-title":"Transcriptomic and CRISPR\/Cas9 technologies reveal FOXA2 as a tumor suppressor gene in pancreatic cancer","volume":"310","author":"Vorvis","year":"2016","journal-title":"Am. J. Physiol. Liver Physiol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/pcmr.12729","article-title":"Analysis of the putative tumor suppressor gene cdkn2ab in pigment cells and melanoma of Xiphophorus and medaka","volume":"32","author":"Regneri","year":"2018","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1159\/000495956","article-title":"Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview","volume":"51","author":"Wang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1080\/15592294.2014.1003746","article-title":"Epigenetic regulation in human melanoma: Past and future","volume":"10","author":"Sarkar","year":"2015","journal-title":"Epigenetics"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1080\/15592294.2017.1311434","article-title":"DNA methylation aberrancies as a guide for surveillance and treatment of human cancers","volume":"12","author":"Liang","year":"2017","journal-title":"Epigenetics"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13073-014-0066-6","article-title":"Pan-cancer patterns of DNA methylation","volume":"6","author":"Witte","year":"2014","journal-title":"Genome Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13148-017-0332-8","article-title":"Aberrant DNA methylation in melanoma: Biomarker and therapeutic opportunities","volume":"9","author":"Micevic","year":"2017","journal-title":"Clin. Epigenetics"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrc1279","article-title":"The history of cancer epigenetics","volume":"4","author":"Feinberg","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10585-009-9273-8","article-title":"Expression and functional analysis of the WAP four disulfide core domain 1 gene in human melanoma","volume":"26","author":"Liu","year":"2009","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/jcp.22568","article-title":"RASSF1A suppresses melanoma development by modulating apoptosis and cell-cycle progression","volume":"226","author":"Yi","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s00018-012-1145-8","article-title":"Suppressor of cytokine signaling 1 blocks mitosis in human melanoma cells","volume":"70","author":"Parrillas","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/exd.12802","article-title":"Suppressor of cytokine signaling-1 (SOCS-1) induces significant preclinical anti-tumor effect in malignant melanoma cells","volume":"24","author":"Serada","year":"2015","journal-title":"Exp. Dermatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/carcin\/bgi152","article-title":"Multiple markers for melanoma progression regulated by DNA methylation: Insights from transcriptomic studies","volume":"26","author":"Gallagher","year":"2005","journal-title":"Carcinogenesis"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1158\/0008-5472.CAN-08-2690","article-title":"Spleen Tyrosine Kinase Functions as a Tumor Suppressor in Melanoma Cells by Inducing Senescence-like Growth Arrest","volume":"69","author":"Bailet","year":"2009","journal-title":"Cancer Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1111\/j.1755-148X.2009.00568.x","article-title":"H-Cadherin expression reduces invasion of malignant melanoma","volume":"22","author":"Kuphal","year":"2009","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.3892\/or.2016.4618","article-title":"DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma","volume":"35","author":"Venza","year":"2016","journal-title":"Oncol. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1007\/s00432-019-02981-5","article-title":"Heterozygous loss of keratinocyte TRIM16 expression increases melanocytic cell lesions and lymph node metastasis","volume":"145","author":"Sutton","year":"2019","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"10127","DOI":"10.18632\/oncotarget.2466","article-title":"TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells","volume":"5","author":"Sutton","year":"2014","journal-title":"Oncotarget"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/cbin.10824","article-title":"Runx3 inhibits melanoma cell migration through regulation of cell shape change","volume":"41","author":"Zhang","year":"2017","journal-title":"Cell Biol. Int."},{"key":"ref_37","first-page":"163","article-title":"Anti-tumor effects of resveratrol on malignant melanoma is associated with promoter demethylation of RUNX3 gene","volume":"74","author":"Kang","year":"2019","journal-title":"Die Pharm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"5215","DOI":"10.1038\/sj.onc.1207647","article-title":"Genetic and epigenetic alterations of the APC gene in malignant melanoma","volume":"23","author":"Worm","year":"2004","journal-title":"Oncogene"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/pcmr.12096","article-title":"Genome-wide promoter methylation analysis identifies epigenetic silencing ofMAPK13in primary cutaneous melanoma","volume":"26","author":"Gao","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1158\/1541-7786.MCR-13-0006","article-title":"Mutual Exclusivity Analysis of Genetic and Epigenetic Drivers in Melanoma Identifies a Link Between p14ARF and RAR\u03b2 Signaling","volume":"11","author":"Dahl","year":"2013","journal-title":"Mol. Cancer Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1038\/s41388-018-0563-y","article-title":"The renin angiotensin system (RAS) mediates bifunctional growth regulation in melanoma and is a novel target for therapeutic intervention","volume":"38","author":"Renziehausen","year":"2018","journal-title":"Oncogene"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0749.2007.00363.x","article-title":"Loss of maspin expression contributes to a more invasive potential in malignant melanoma","volume":"20","author":"Denk","year":"2007","journal-title":"Pigment Cell Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1476-4598-8-53","article-title":"14-3-3sigma gene silencing during melanoma progression and its role in cell cycle control and cellular senescence","volume":"8","author":"Schultz","year":"2009","journal-title":"Mol. Cancer"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/carcin\/bgr138","article-title":"Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS1 in metastatic melanoma","volume":"32","author":"Arab","year":"2011","journal-title":"Carcinogenesis"},{"key":"ref_45","first-page":"864","article-title":"Epigenetic silencing of putative tumor suppressor SPINT2\/HAI-2 in melanoma","volume":"25","author":"Hwang","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.4161\/15592294.2014.983361","article-title":"RASSF6 exhibits promoter hypermethylation in metastatic melanoma and inhibits invasion in melanoma cells","volume":"9","author":"Mezzanotte","year":"2014","journal-title":"Epigenetics"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/j.0022-202X.2005.23685.x","article-title":"The Non-Receptor-Associated Tyrosine Kinase Syk is a Regulator of Metastatic Behavior in Human Melanoma Cells","volume":"124","author":"Hoeller","year":"2005","journal-title":"J. Investig. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1158\/1078-0432.CCR-08-3172","article-title":"Regulation of RUNX3 tumor suppressor gene expression in cutaneous melanoma","volume":"15","author":"Kitago","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/cncr.25838","article-title":"Prognostic significance of RUNX3 expression in human melanoma","volume":"117","author":"Zhang","year":"2011","journal-title":"Cancer"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"84210","DOI":"10.18632\/oncotarget.20476","article-title":"Inhibition of retinoic acid receptor \u03b2 signaling confers glycolytic dependence and sensitization to dichloroacetate in melanoma cells","volume":"8","author":"Abildgaard","year":"2017","journal-title":"Oncotarget"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1159\/000453189","article-title":"Effects of CDKN2A (p16INK4A\/p14ARF) Over-Expression on Proliferation and Migration of Human Melanoma A375 Cells","volume":"40","author":"Bai","year":"2016","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jnci\/djk053","article-title":"Requirement of KISS1 Secretion for Multiple Organ Metastasis Suppression and Maintenance of Tumor Dormancy","volume":"99","author":"Nash","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1593\/neo.121444","article-title":"IRF-8 Controls Melanoma Progression by Regulating the Cross Talk between Cancer and Immune Cells within the Tumor Microenvironment","volume":"14","author":"Mattei","year":"2012","journal-title":"Neoplasia"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1349-7006.1998.tb00577.x","article-title":"Reduced Invasive and Metastatic Potentials ofKAI1-transfected Melanoma Cells","volume":"89","author":"Takaoka","year":"1998","journal-title":"Jpn. J. Cancer Res."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/excr.2001.5452","article-title":"Suppression of Human Melanoma Metastasis by the Metastasis Suppressor Gene, BRMS1","volume":"273","author":"Shevde","year":"2002","journal-title":"Exp. Cell Res."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/19\/10674\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:08:35Z","timestamp":1760166515000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/19\/10674"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":55,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["ijms221910674"],"URL":"https:\/\/doi.org\/10.3390\/ijms221910674","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}